Activation of natural killer T cells by α-galactosylceramide in the presence of CD1d provides protection against colitis in mice

Lawrence J. Saubermann(Brigham and Women's Hospital), Paul L. Beck(Massachusetts General Hospital), Ype P. de Jong(Beth Israel Deaconess Medical Center), Richard S. Pitman(Brigham and Women's Hospital), Mark Ryan(Brigham and Women's Hospital), Hyun S. Kim(Brigham and Women's Hospital), Scott B. Snapper(Massachusetts General Hospital), Susan J. Hagen(Beth Israel Deaconess Medical Center), Osamu Kanauchi(Kirin (Japan)), Kazuhiro Motoki(Kirin (Japan)), Teruyuki Sakai(Kirin (Japan)), Cox Terhorst(Beth Israel Deaconess Medical Center), Yasuhiko Koezuka(Kirin (Japan)), Daniel K. Podolsky(Massachusetts General Hospital), Richard S. Blumberg(Brigham and Women's Hospital), Mark A. Exley, Steven P. Balk
Gastroenterology
July 1, 2000
Cited by 212Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis